In 1980, Ludwig and colleagues described the histologic features of a newly identified chronic liver condition referred to as nonalcoholic steatohepatitis (NASH) and noted that the majority of the ... EurekAlert!: Expert consensus on clinical applications of fecal microbiota transplantation for chronic liver disease (2025 edition) Expert consensus on clinical applications of fecal microbiota transplantation for chronic liver disease (2025 edition) News Medical: Myosteatosis: An emerging predictor of outcomes in chronic liver disease Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of poor clinical outcomes across a spectrum of liver diseases. However, the field ...

Understanding the Context

Liver cancer is one of the world's deadliest cancers, and most cases are linked to chronic viral hepatitis. Yet scientists have lacked an animal model that faithfully recapitulates how the disease ... Liver fibrosis may be diagnosed and staged โ€” no fibrosis (stage F0), mild fibrosis (F1), significant fibrosis (F2), advanced fibrosis (F3), and cirrhosis (F4) โ€” with the use of clinical parameters and ... Liver transplants often save the lives of seriously ill patients.

Key Insights

However, there remains a risk that the body will reject the new organ. Doctors distinguish between acute and chronic rejection. While ...